Ziad Ali, MD
Internal Medicine · New York, NYNPI 1588844245
Payments from drug & device makers
Across 1,344 payments — averaging $2420.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shockwave Medical, Inc$1.3M
- Abbott$606K
- Spectrawave, Inc$275K
- Philips North America LLC$187K
- Boston Scientific$172K
- AstraZeneca$152K
- plus $513K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shockwave Medical, Inc | 419 | $1,347,278 |
| Abbott | 308 | $606,434 |
| Spectrawave, Inc | 13 | $275,122 |
| Philips North America LLC | 96 | $186,541 |
| Boston Scientific | 132 | $172,266 |
| AstraZeneca | 137 | $152,285 |
| Edwards Lifesciences | 46 | $131,468 |
| Heartflow, Inc. | 18 | $122,810 |
| Acist Medical Systems, Inc. | 37 | $86,321 |
| Novartis | 4 | $66,060 |
| Abiomed | 45 | $47,197 |
| Amgen | 12 | $20,616 |
| Opsens Inc. | 7 | $14,380 |
| Cathworks, Inc. | 10 | $13,980 |
| Medtronic(2 entities) | 36 | $3,748 |
| Siemens Medical Solutions USA, Inc. | 1 | $3,500 |
| Terumo Medical Corporation | 1 | $550 |
| Biotronik Inc. | 4 | $351 |
| Fresenius USA Marketing, Inc. | 1 | $249 |
| Cardiovascular Systems Inc. | 4 | $248 |
| Neovasc Medical Inc | 1 | $210 |
| Recor Medical Inc | 1 | $157 |
| Asahi Intecc USA, Inc. | 1 | $146 |
| ZOLL Circulation Inc | 1 | $130 |
| Arrow International, Inc. | 1 | $118 |
| Angiodynamics, Inc. | 2 | $109 |
| W. L. Gore & Associates, Inc. | 1 | $89 |
| Artivion, Inc. | 1 | $35 |
| Kestra Medical Technology Services, Inc. | 1 | $31 |
| GE HealthCare | 1 | $23 |
| Merck | 1 | $19 |
| Boehringer Ingelheim | 1 | $18 |
How this compares
$3,252,491 in reported general payments places this provider in the 95th percentile of 9,771 internal medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in New York
- Helena YuNew York$50.9M
- Neha KordeNew York$21.2M
- Karen AutioNew York$18.5M
- Ingo MellinghoffNew York$16.1M
- Gopakumar IyerNew York$12.4M
- Sally LauNew York$8.4M
- Maria RubinsteinNew York$6.3M
- Dana RathkopfNew York$6M
- Eytan SteinNew York$5.8M
- James GreenwaldNew York$4.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.